Uniqure

Uniqure

Yahoo Finance • 28 days ago

uniQure Announces Pricing of Upsized $225 Million Public Offering

LEXINGTON, Mass. and AMSTERDAM, June 23, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its p... Full story

Yahoo Finance • 29 days ago

uniQure Announces $150 Million Proposed Public Offering

LEXINGTON, Mass. and AMSTERDAM, June 22, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commence... Full story

Yahoo Finance • last month

SpaceX initiated, Salesforce upgraded: Wall Street's top analyst calls

SpaceX initiated, Salesforce upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compile... Full story

Yahoo Finance • last month

Top Biotech Gainers: QURE Rallies On AMT-130 Update, LNAI On Track, FTH Eyes Q4 Data, ELTX On Watch

(RTTNews) - Today's top gainers included uniQure, which rallied after the FDA softened its stance on the company's investigational gene therapy; Elicio Therapeutics, following encouraging treatment responses from its cancer vaccine in panc... Full story

Yahoo Finance • last month

Stocks Retreat as Fed Signals Possible Higher Interest Rates

The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -1.21%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.98%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.99%.  June E-mini S&P futures (ESM26) fell -1.19%, and... Full story

Yahoo Finance • last month

Stocks Mixed Ahead of FOMC Meeting Results

The S&P 500 Index ($SPX) (SPY) today is down -0.15%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.23%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.30%.  June E-mini S&P futures (ESM26) are down -0.17%, and June E-mini Nasdaq... Full story

Yahoo Finance • last month

Wednesday Sector Leaders: Computers, Biotechnology Stocks

In trading on Wednesday, computers shares were relative leaders, up on the day by about 5.6%. Leading the group were shares of AstroNova, up about 70.2% and shares of Nano Dimension Ltd (NNDM) up about 9.8% on the day. Also showing relat... Full story

Yahoo Finance • last month

Stocks Supported by Chip Stock Strength and Strong US Retail Sales

The S&P 500 Index ($SPX) (SPY) today is up +0.23%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.26%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.74%.  June E-mini S&P futures (ESM26) are up +0.19%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • last month

UniQure, Aehr Test Systems surge premarket; Snap, Leidos fall

Investing.com - U.S. stock futures were broadly steady on Wednesday as investors geared up for a key Federal Reserve interest rate decision and monitored reports on the details of a preliminary Middle East peace agreement. By 08:40 ET (01... Full story

Yahoo Finance • 2 months ago

Considering Uniqure NV (QURE) Stock? Read the AMT-130 Message

Uniqure NV (NASDAQ:QURE) is one of the best gene therapy stocks to buy in 2026. Uniqure shares have gained 60% over the past month and more than doubled over the past year. The Street believes the stock’s rally isn’t done yet and anticipat... Full story

Yahoo Finance • 3 months ago

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~ ~ Progressing AMT-130 toward expected UK regulatory submission; MAA on track for third quarter of 2026 following s... Full story

Yahoo Finance • 3 months ago

UniQure Advances Toward UK Filing For AMT-130 After Positive MHRA Pre-Submission Meeting; Stock Up

(RTTNews) - uniQure N.V. (QURE) said it has completed a successful pre-submission meeting with the UK Medicines and Healthcare products Regulatory Agency (MHRA), clearing the path for a planned Marketing Authorization Application (MAA) for... Full story

Yahoo Finance • 3 months ago

uniQure N.V. (QURE) Stock Posts 30% Growth from Last Year

uniQure N.V. (NASDAQ:QURE) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The stock registered a 32.28 percent growth in the past year and a 24.84 percent year-to-date decline.Is uniQure N.V. (QURE) the Most Promi... Full story

Yahoo Finance • 3 months ago

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure N.V. Lawsuit – QURE

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losse... Full story

Yahoo Finance • 3 months ago

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violatio... Full story

Yahoo Finance • 3 months ago

QURE FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “C... Full story

Yahoo Finance • 3 months ago

מועד אחרון לתביעה הייצוגית נגד QURE: רוזן, משרד עורכי דין מוביל, מעודד משקיעים ב-uniQure N.V עם הפסדים העולים על 100,000 דולר לקבל ייעוץ משפטי לפני המועד החשוב ב-13 באפריל בתביעה ייצוגית בניירות ערך – QURE

ניו יורק, April 09, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את המניות הרגילות של uniQure N.V. (נאסד"ק: QURE) בין התאריכים 24 בספטמבר 2025 עד 31 ב... Full story

Yahoo Finance • 3 months ago

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Who is Involved: uniQure N.V. (NasdaqGS: QURE) investors that purchased between September 24, 2025 and October 31, 2025When to Act: Deadline to file Lead Plaintiff applications is April 13, 2026Basis: uniQure shares fell on disclosure of F... Full story

Yahoo Finance • 3 months ago

UNIQURE N.V. (NASDAQ: QURE) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 13, 2026

PHILADELPHIA, April 06, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against uniQure N.V.(NASDAQ: QURE) (“uniQure” or the “Company”) on behalf of investors... Full story

Yahoo Finance • 4 months ago

UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “C... Full story